Space exploration – Jenam 2011 Wed, 29 Jun 2022 03:39:15 +0000 en-US hourly 1 Space exploration – Jenam 2011 32 32 Triple Ring Technologies and The Hines Family Foundation collaborate on Nanolab BioModule Wed, 29 Jun 2022 01:23:33 +0000

Triple Ring Technologies and The Hines Family Foundation collaborate on Nanolab BioModule

Press release from: Triple Ring Technologies
Posted: Tuesday June 28th 2022

The Hines Family Foundation for Education, Innovation and Service (HFF) SILVA Nanolab YCC01 BioModule was successfully delivered to the International Space Station (ISS) via SpaceX Crew-4 on April 27, 2022. Developed by the HFF EXPLORES program and the Space Innovation and Learning Virtual Academy (SILVA), the YCC01 Biological Cell Culture Spaceflight Technology Demonstration Project will be used to study the effect of microgravity on the functional behavior and growth of Saccharomyces cerevisiae (baker’s yeast) grown onboard the ISS over 30 days compared to samples grown on land. The Nanolab YCC01 is the first general educational training tool of its kind for students and teachers interested in learning more about the effects of space on living systems.

The YCC01 project was born out of a collaboration with scientists and technologists from NASA’s Biosentinel program and HFF product development partners, including Triple Ring Technologies. Biosentinel is NASA’s first biological mission to fly in deep space, and students working with YCC01 will have the opportunity to conduct parallel experiments in their schools.

“The YCC01 platform provides a wonderful opportunity for students to conduct in-flight and ground-based experiments similar to those performed in formal NASA science missions. This has implications not only for space exploration, but also for making advance student interest in cellular and molecular biology, the effects of space exploration and radiation exposure on living systems, the development of biological spaceflight systems, genomics, synthetic biology, and biomanufacturing , to name a few.I believe that working alongside NASA and with the mentorship of other scientists and specialists will motivate students to learn and prepare for future careers in these exciting fields enabled by STEM,” said John Hines, founder of HFF. Following this first flight on the ISS, HFF plans to develop further class and laboratory devices. e for STEM students, STEM learning exercises and hands-on project experiences, both virtually and with complementary home and/or school learning kits.

“The SILVA Virtual Academy designed, developed and delivered the YCC01 biomodule in an incredible 120 days! Teams worked remotely, but with tight integration, throughout the global pandemic to accomplish this impressive feat. We launched the YCC01 biomodule in ISS compatibility The NanoRacks on board SpaceX Crew-4 and the systems are now onboard and operational,” commented Greg Kovacs, Chief Medical Officer at Triple Ring Technologies, and Chief Engineer and Head of Electronics for the project.

Joe Heanue, CEO of Triple Ring Technologies, “Triple Ring is proud to support the Hines Family Foundation in pursuing its mission to help underserved and underrepresented students learn and apply technology skills and engineering needed to thrive and thrive in the 21st century STEM enabled workforce.”

HFF plans to launch pilot deployments of STEM student classrooms and NanoLabs biological cell culture labs during World Space Week (October 4-10, 2022) in Atlanta, GA.

Additional information can be found at the following links:

Hines Family Foundation:

International Space Station:

NASA BioSentinel:

Triple Ring Technologies:

About Triple Ring Technologies: Triple Ring Technologies is a Silicon Valley-based co-development company with offices in Boston, Toronto and Copenhagen. They partner with medical technology, life science, sustainability and environmental clients to create new technologies, launch innovative projects and start new businesses. Their capabilities span early R&D, product development, manufacturing, regulatory approval, market access, strategic investment and incubation. For more information, please visit

About the Hines Family Foundation: The Hines Family Foundation for Education, Innovation, and Service (HFF) ( is a private, nonprofit operating foundation based in Atlanta, Georgia, whose mission is to enable students, groups, and communities to become viable contributors and recipients of the 21st century global workforce through STEM4-based learning and innovation. 0. Using technical foundations and experiences derived from NASA space programs, HFF develops and enables academics, teams, learning lessons, training programs, and real-world hands-on project experiences to motivate learning and training to support and encourage student and teacher interest and involvement. A specific goal of HFF is to train students to use and apply the technology and engineering skills and abilities needed to thrive and prosper.

// end //

No more press releases and status reports or featured stories.

Please follow SpaceRef on Twitter and Like us on Facebook.

BWXT Medical Enters into Commercial Agreement with Bayer to Supply Actinium-225 Products Mon, 27 Jun 2022 10:45:00 +0000

OTTAWA, Ontario–(BUSINESS WIRE)–BWX Technologies, Inc. (NYSE: BWXT) today announced that its subsidiary BWXT Medical Ltd. has signed a commercial agreement with Bayer AG (Bayer) to supply high purity actinium-225 (Ac-225).

Today’s announcement follows the agreement the two companies reached in September 2021. Under the terms of the commercial agreement, Bayer will purchase high-purity Ac-225 from BWXT Medical at pre-determined prices . The parties expect procurement to begin later this year.

Ac-225 is a very potent radioisotope used in targeted alpha therapies (TAT). This emerging field combines Ac-225 with tumor-specific targeting fragments, which deliver alpha radiation directly to tumors.

BWXT Medical is a global supplier of medical isotopes and radiopharmaceuticals. Bayer is a global company with core competencies in the fields of life sciences, health and nutrition.

“We are very pleased to enter into this agreement with Bayer, one of the world leaders in the growing field of targeted radionuclide therapies,” said Martyn Coombs, president of BWXT Medical. “Targeted radiation therapies are being developed to improve outcomes for patients with different types of cancers. We will leverage our strengths in nuclear medicine to work with Bayer for the long term. »

Forward-looking statements

BWXT cautions that this release contains forward-looking statements, including statements relating to expectations regarding the development, production, performance, demand, timing and impact of Ac-225. These forward-looking statements involve a number of risks and uncertainties, including, among other things, changes in market demand, delays in the development and automation of our production, regulatory approvals and competitive actions. If one or more of these or other risks materialize, actual results may differ materially from those expressed. For a more complete discussion of these and other risk factors, please see BWXT’s Annual Report on Form 10-K for the year ended December 31, 2021 and subsequent Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission. BWXT cautions not to place undue reliance on these forward-looking statements, which speak only as of the date of this release, and undertakes no obligation to update or revise any forward-looking statement, except as required. by applicable law.

About BWXT

At BWX Technologies, Inc. (NYSE: BWXT), we are strong, innovation-driven people. Based in Lynchburg, Va., BWXT is a Fortune 1000 and Defense News Top 100 manufacturing and engineering innovator that provides safe and effective nuclear solutions for global security, clean energy, environmental sanitation environment, nuclear medicine and space exploration. With approximately 6,700 employees, BWXT has 14 major operating sites in the United States, Canada and the United Kingdom. In addition, BWXT joint ventures manage and operate more than a dozen US Department of Energy and NASA facilities. Follow us on Twitter at @BWXT and learn more about

]]> ‘Blade Runner’ at 40: Director Ridley Scott’s dystopian masterpiece Sat, 25 Jun 2022 14:28:50 +0000

It’s a daunting task to imagine a more pivotal year for classic Hollywood genre films than 1982. Trek II: Wrath of Khan, “The Thing”, “ET the Extra-Terrestrial”, “The Dark Crystal”, “Tron”, “Conan the Barbarian”, and director Ridley Scott’s neo-noir gem, ” Blade Runner”.

Warner Bros.’ ‘Blade Runner’ opened on June 25, 1982 to mediocre reception upon release and was far from the influential masterpiece that is now considered one of the greatest sci-fi films of all. the temperature. Its dystopian story of a future 2019 Los Angeles that has become a crumbling megalopolis and its team of anti-android assassins was adapted from award-winning author Philip K. Dick’s 1968 novel “Do Androids Dream of electric sheep? (opens in a new tab)Here’s our streaming guide for the Blade Runner franchise if you need to catch up.